CYSTARAN for treatment of corneal cystine accumulation now available

CYSTARAN, the first and only FDA approved therapy for the treatment of corneal cystine accumulation in patients with cystinosis, is now available. The CYSTARAN hotline (1-800-440-0473) is available to patients, caregivers and physicians. Pharmacy services include coordination of direct-to-patient delivery of CYSTARAN and reimbursement support. The order form is available here. More information about the drug and the patient assistance program can be found at http://www.cystaran.com.